Dermal Fillers Market are substances that are injected into the skin to add volume and fullness. Calcium hydroxylapatite, hyaluronic acid, polyalkylimide, polylactic acid, and polymethyl-methacrylate microspheres are among the ingredients used in dermal fillers. Dermal fillers are classified according to several criteria, including depth of implantation, the longevity of correction, and agent composition. Another criterion is stimulatory behavior and replacement fillers.
End-use segments include specialty dermatology clinics, hospitals, and others. This segment is expected to dominate the market as dermatology clinics perform redundant aesthetic procedures. Furthermore, the increasing number of specialized dermatology clinics in developing countries is driving the market growth.
By region, Asia-Pacific is expected to grow at the fastest CAGR during the forecast period, owing to an aging population and rising per capita income. Rising demand for facial aesthetics products and non-invasive cosmetic procedures are expected to drive the market in the region during the assessment period. Due to the presence of lucrative opportunities in developing nations such as India and China is expected to play a significant role in strengthening the regional dermal fillers market.
The market is projected to grow at a significant pace reaching a CAGR of approximately 8.6%, over the forecast period of 2022–2028, despite a considerable fall in product sales during the initial phase of pandemic spread and lockdown restrictions imposed globally.
The study is consolidated into major segments and further into sub-segments, such as by Product Type (Biodegradable, Non-Biodegradable), by Material Type (Hyaluronic Acid, Calcium Hydroxyapatite, Polymethyl-Methacrylate Microspheres, Others), by Application (Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement, Restoration of Volume, Other), End-User (Specialty Dermatology Clinics, Hospitals, Others), to forecast the Dermal Fillers Market size by value; also includes the analysis of past market dynamics from 2016 – 2021, considering 2021 as the base year.
Lastly, the report includes a regional analysis and country analysis with the latest trends, along with the major key players including Galderma Pharma S.A, Sinclair Pharma plc, AbbVie Inc., Anika Therapeutics Inc., Merz Pharma GmbH Co. KGaA, Suneva Medical Inc., Teoxane Laboratories Inc., Prollenium Medical Technologies Inc., Laboratoires Vivacy SAS, Fidia Pharma USA Inc., Zimmer Biomet Holdings.
Contact:
Market Research Community
sales@marketresearchcommunity.com
